These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 22550537)

  • 1. Suboptimal immune reconstitution in vertically HIV infected children: a view on how HIV replication and timing of HAART initiation can impact on T and B-cell compartment.
    Cotugno N; Douagi I; Rossi P; Palma P
    Clin Dev Immunol; 2012; 2012():805151. PubMed ID: 22550537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incomplete immune recovery in HIV infection: mechanisms, relevance for clinical care, and possible solutions.
    Gaardbo JC; Hartling HJ; Gerstoft J; Nielsen SD
    Clin Dev Immunol; 2012; 2012():670957. PubMed ID: 22474480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular immune responses in human immunodeficiency virus (HIV)-1-infected children: is immune restoration by highly active anti-retroviral therapy comparable to non-progression?
    Hainaut M; Verscheure V; Ducarme M; Schandené L; Levy J; Mascart F
    Clin Exp Immunol; 2011 Jul; 165(1):77-84. PubMed ID: 21501151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression.
    Darraj M; Shafer LA; Chan S; Kasper K; Keynan Y
    J Infect Public Health; 2018; 11(2):265-269. PubMed ID: 28826735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up.
    Resino S; Resino R; Micheloud D; Gurbindo Gutiérrez D; Léon JA; Ramos JT; Ciria L; de José I; Mellado J; Muñoz-Fernández A;
    Clin Infect Dis; 2006 Mar; 42(6):862-9. PubMed ID: 16477566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications of discordant viral and immune outcomes following protease inhibitor containing antiretroviral therapy for HIV-infected children.
    Rodriguez CA; Koch S; Goodenow M; Sleasman JW
    Immunol Res; 2008; 40(3):271-86. PubMed ID: 17952387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of long-term highly active antiretroviral therapy in restoring HIV-induced abnormal B-lymphocyte function.
    Jacobson MA; Khayam-Bashi H; Martin JN; Black D; Ng V
    J Acquir Immune Defic Syndr; 2002 Dec; 31(5):472-7. PubMed ID: 12473834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal outcomes after HAART for the prevention of mother-to-child transmission in HIV-infected women in Brazil.
    Pilotto JH; Velasque LS; Friedman RK; Moreira RI; Veloso VG; Grinsztejn B; Morgado MG; Watts DH; Currier JS; Hoffman RM
    Antivir Ther; 2011; 16(3):349-56. PubMed ID: 21555817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of exhausted B cells in asymptomatic HIV-1-infected patients naïve for HAART is related to reduced immune surveillance.
    Fogli M; Torti C; Malacarne F; Fiorentini S; Albani M; Izzo I; Giagulli C; Maggi F; Carosi G; Caruso A
    Clin Dev Immunol; 2012; 2012():829584. PubMed ID: 22474482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of the T-cell receptor CD4 and CD8 V beta repertoire in HIV-1 vertically infected infants early treated with HAART.
    Romiti ML; Cancrini C; Castelli-Gattinara G; Di Cesare S; Ciaffi P; Bernardi S; De Gasperi MR; Halapi E; Rossi P
    AIDS; 2001 Nov; 15(16):2075-84. PubMed ID: 11684926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timing of HAART defines the integrity of memory B cells and the longevity of humoral responses in HIV-1 vertically-infected children.
    Pensieroso S; Cagigi A; Palma P; Nilsson A; Capponi C; Freda E; Bernardi S; Thorstensson R; Chiodi F; Rossi P
    Proc Natl Acad Sci U S A; 2009 May; 106(19):7939-44. PubMed ID: 19416836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART.
    Aiuti F; Mezzaroma I
    AIDS Rev; 2006; 8(2):88-97. PubMed ID: 16848276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Complete immune and clinical recovery after highly active antiretroviral therapy in advanced vertically HIV-1 infected children].
    Resino S; Sánchez-Ramón S; Correa R; Navarro ML; Bellón JM; Muñoz-Fernández MA
    Med Clin (Barc); 2003 Mar; 120(11):417-20. PubMed ID: 12681220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of HAART on survival, weight gain and resting energy expenditure in HIV-1-infected children in India.
    Banerjee T; Pensi T; Banerjee D; Grover G
    Ann Trop Paediatr; 2010; 30(1):27-37. PubMed ID: 20196931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited immune restoration after 3 years' suppression of HIV-1 replication in patients with moderately advanced disease.
    Valdez H; Connick E; Smith KY; Lederman MM; Bosch RJ; Kim RS; St Clair M; Kuritzkes DR; Kessler H; Fox L; Blanchard-Vargas M; Landay A;
    AIDS; 2002 Sep; 16(14):1859-66. PubMed ID: 12351945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term immunological response in HIV-1-infected subjects receiving potent antiretroviral therapy.
    Kaufmann GR; Bloch M; Zaunders JJ; Smith D; Cooper DA
    AIDS; 2000 May; 14(8):959-69. PubMed ID: 10853977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune reconstitution in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy: a cohort study.
    Johnston AM; Valentine ME; Ottinger J; Baydo R; Gryszowka V; Vavro C; Weinhold K; St Clair M; McKinney RE
    Pediatr Infect Dis J; 2001 Oct; 20(10):941-6. PubMed ID: 11642627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of suppression of viral replication by highly active antiretroviral therapy on immune function and phenotype in chronic HIV-1 infection.
    Lange CG; Lederman MM; Madero JS; Medvik K; Asaad R; Pacheko C; Carranza C; Valdez H
    J Acquir Immune Defic Syndr; 2002 May; 30(1):33-40. PubMed ID: 12048361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterizing the immune system after long-term undetectable viral load in HIV-1-infected children.
    Resino S; Galán I; Bellón JM; Navarro ML; León JA; Muñoz-Fernandez MA
    J Clin Immunol; 2003 Jul; 23(4):279-89. PubMed ID: 12959220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of progression markers in a non-study population of human immunodeficiency virus-1 vertically infected infants with different antiretroviral treatments.
    Resino S; Bellón JM; Gurbindo D; Ramos JT; León JA; Muñóz-Fernández MA
    Acta Paediatr; 2002; 91(7):776-82. PubMed ID: 12200902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.